drugset / Trial / NCT00276380
A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the effectiveness of Tanakan® 240mg in association with Acetylsalicylic acid (325mg/day) in the recovery of neurological impairment following ischemic stroke.
Timeline
- Start
- 2003-02
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ginkgo Biloba Extract | Traditional medicine (herbal / TCM) | 240 mg | Oral |
| Background | Aspirin | Small molecule | 325 mg | — |